Drug treatment of AIDS dementia, PET scan

Drug treatment of AIDS dementia, PET scan

M112/0402 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 25.1MB

Downloadable file size: 683.6KB

Price image Pricing

Please login to use the price calculator

This image is part of the sequence Healthcare: PET scans of the brain of an AIDS patient before and after drug treatment


Caption: Drug treatment of AIDS dementia. Coloured positron emission tomography (PET) scans of axial sections through the human brain. The brain at left (1) is that of a normal control subject. The brain at centre (2) is that of an AIDS (acquired immune deficiency disorder) patient suffering dementia.At right (3) is the same patient 13 weeks after treatment with the anti-retroviral drug AZT (azidothymidine). The increase in red, yellow and green areas denotes a rise in glucose metabolism, indicating an improvement in brain function. PET scans use gamma cameras to detect radioactive tracers that have been injected into the blood, and which accumulate in areas of high metabolic activity.

Release details: Model release not required. Property release not required.

Keywords: abnormal, acquired immune deficiency, aids, aids dementia, anti-retroviral, anti-viral, antiretroviral, antiviral, atrophy, axial, azidothymidine, azt, before and after, brain, brain scan, cerebral atrophy, coloured, compare, comparison, condition, dementia, disease, disorder, drug, drugs, false-colour, false-coloured, glucose metabolism, healthcare, healthy, hiv, human body, human immunodeficiency virus, medical, medicine, neuroimaging, neurological, neurology, normal, organ, pet scan, positron emission tomography, post, post-treatment, pre, prior, scanner, section, sectioned, sections, syndrome, therapy, three, treatment, trio, unhealthy, virology, zdv, zidovudine

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.